Cargando…
Convalescent plasma therapy in COVID-19 and discharge status: A systematic review
OBJECTIVE: Covid19 has emerged as a greatest threat of the decade worldwide. At present there is no certain treatment for treating coronavirus diseases, while some antiviral drugs (Remdesivir , Lopinavir and Ritonavir) are under investigation. Many countries including India have adopted the convales...
Autores principales: | Agarwal, Neeraj, Mishra, Shradha, Ayub, Arshad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653454/ https://www.ncbi.nlm.nih.gov/pubmed/34934695 http://dx.doi.org/10.4103/jfmpc.jfmpc_2429_20 |
Ejemplares similares
-
Immunization coverage among children aged 12-23 months: A cross sectional study in low performing blocks of Bihar, India
por: Singh, C. M., et al.
Publicado: (2019) -
Bioethical perspective of convalescent plasma therapy for COVID-19: A systematic review
por: Munir, M.A., et al.
Publicado: (2021) -
Current Perspectives of convalescent plasma therapy in COVID-19
por: Sahu, Kamal Kant, et al.
Publicado: (2020) -
Reviewing the Ethical Concerns of the Convalescent Plasma Therapy in COVID-19
por: Raturi, Manish, et al.
Publicado: (2021) -
Convalescent plasma therapy in patients with COVID-19
por: Altuntas, Fevzi, et al.
Publicado: (2021)